Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots

Clinical Chemistry

Volumn 54, Issue 4, 2008, Pages 657-664

  Turgeon, Coleman ^a   Magera, Mark J ^a   Allard, Pierre ^b   Tortorelli, Silvia ^a   Gavrilov, Dimitar ^a   Oglesbee, Devin ^a   Raymond, Kimiyo ^a   Rinaldo, Piero ^a   Matern, Dietrich ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ACYLCARNITINE; AMINO ACID DERIVATIVE; METHANOL; SUCCINYLACETONE; AMINO ACID; CARNITINE; DRUG DERIVATIVE; HEPTANOIC ACID DERIVATIVE;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW INJECTION ANALYSIS; HUMAN; NEWBORN; NEWBORN SCREENING; TANDEM MASS SPECTROMETRY; TYROSINEMIA; BLOOD; BLOOD SAMPLING; METHODOLOGY; RETROSPECTIVE STUDY;

AMINO ACIDS; BLOOD SPECIMEN COLLECTION; CARNITINE; FLOW INJECTION ANALYSIS; HEPTANOATES; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; RETROSPECTIVE STUDIES; TANDEM MASS SPECTROMETRY; TYROSINEMIAS;

EID: 42449118446     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.101949     Document Type: Article

References (17)

1. Mitchell GA, Grompe M, Lambert M, Tanguay RM. Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. vol. 2, 8th ed. New York: McGraw-Hill, 2001;1777-805.
2. Holme E, Lindstedt S. Nontransplant treatment of tyrosinemia. Clin Liver Dis 2000;4:805-14.
3. Alvarez F, Bussieres J-F, Dallaire L, Dubois J, Faucher F, Fenyves D, et al. Nitisinone (NTBC) treatment of hepatorenal tyrosinemia in Quebec. J Inherit Metab Dis 2005;28:49.
4. Grenier A, Lescault A, Laberge C, Gagne R, Mamer O. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia. Clin Chim Acta 1982;123:93-9.
5. Allard P, Grenier A, Korson MS, Zytkovicz TH. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. Clin Biochem 2004;37:1010-5.
6. Sander J, Janzen N, Peter M, Sander S, Steuerwald U, Holtkamp U, et al. Newborn screening for hepatorenal tyrosinemia: tandem mass spectrometric quantification of succinylacetone. Clin Chem 2006;52:482-7.
7. Schulze A, Frommhold D, Hoffmann GF, Mayatepek E. Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I. Clin Chem 2001;47:1424-9.
8. Magera MJ, Gunawardena ND, Hahn SH, Tortorelli S, Mitchell GA, Goodman SI, et al. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Mol Genet Metab 2006;88:16-21.
9. Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 2001;47:2040-4.
10. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001;47:1166-82.
11. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003;49:1797-817.
12. Chace DH, Kalas TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 2005;38:296-309.
13. Watson MS, Lloyd-Puryear MA, Mann MY, Rinaldo P, Howell RR. Newborn screening: toward a uniform screening panel and system. Genet Med 2006;8:1S-252S.
14. Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). J Inherit Metab Dis 2007;30:585-92.
15. Weigel JF, Janzen N, Pfaffle RW, Thiery J, Kiess W, Ceglarek U. Tandem mass spectrometric determination of succinylacetone in dried blood spots enables presymptomatic detection in a case of hepatorenal tyrosinaemia. J Inherit Metab Dis 2007;30:610.
16. Frazier DM, Millington DS, McCandless SE, Koeberl DD, Weavil SD, Chaing SH, Muenzer J. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 2006;29:76-85.
17. Rinaldo P, Zafari S, Tortorelli S, Matern D. Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. Ment Retard Dev Disabil Res Rev 2006;12:255-61.